“The courts must stand up to this abuse of power, which contradicts the very rationale for representative democracy,” Libby said.
He questioned how much benefit yearly vaccinations continue to offer. In a podcast shortly before assuming his FDA job, Prasad suggested companies could study about 20,000 older adults in August or September to show if an updated vaccine prevented COVID-related hospitalizations.There is “legitimate debate about who should be boosted, how frequently they should be boosted and the value of boosting low-risk individuals,” said Hopkins’ Adalja. But he stressed that CDC’s Advisory Committee on Immunization Practices has the proper expertise to be making those decisions.
And other experts say simply updating the strain that a COVID-19 vaccine targets doesn’t make it a new product — and real-world data shows each fall’s update has offered benefit.“The data are clear and compelling” that vaccination reduces seniors’ risk of hospitalization and serious illness for four to six months, said Michael Osterholm, a University of Minnesota infectious disease researcher.Nor could that kind of study be accomplished quickly enough to get millions of people vaccinated before the yearly winter surge, said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.
“You’d always be doing clinical trials and you’d never have a vaccine that was up to date,” he said.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
WASHINGTON (AP) — In just two months as the federal health secretary,
has made sweeping changes to the Department of Health and Human Services — and its priorities.“Very importantly, we are discussing how to build new regional economic value chains that link our countries, including with American private sector investment,” he said.
Trump’s senior adviser for Africa, Massad Boulos, the father-in-law of Trump’s daughter Tiffany, helped broker the U.S. role in promoting security in east Congo, part of an opening that Boulos has said could involve multibillion-dollar investments.The response from Congolese civil society Friday mixed hope with skepticism.
Rights advocate Christophe Muisa in Goma, a city in east Congo that the powerful, Rwandan-backed M23 armed group seized earlier this year, said the U.S. is the main beneficiary of the deal. He urged his government not to “subcontract its security.”Georges Kapiamba, the president of the Congolese Association for the Access to Justice, a nongovernmental organization focusing on rights, justice and addressing corruption, said he supported a mineral-and-security deal with the U.S., but worried his own government could blow it by siphoning off the proceeds.